Althea Group Holdings (ASX:AGH) executed a definitive asset sale agreement to divest certain assets of its wholly-owned unit, Althea, to Tasmanian Botanics for a consideration of AU$1 million and a profit-sharing component, according to a Friday bourse filing.
The consideration includes a AU$50,000 deposit, which was already paid, and a 50% net profit share on sales of specified residual pharmaceutical inventory.
The assets include Althea trademarks, brand goodwill, website, phone number, and pharmacy/prescriber data.
The deal is expected to be completed in June, per the filing. Tasmanian Botanics will act as Althea Group's agent for a six-month period after completion to sell the remaining Althea-branded inventory.
The company will use the proceeds to strengthen its balance sheet through targeted debt repayment. The firm said it will focus entirely on its North American tetrahydrocannabinol-infused beverage operations under the Peak Processing Solutions banner.
Althea Group Holdings' shares jumped over 4% in recent trading on Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.